Ekhlasian Alireza, Eftekhar Ebrahim, Daei Sajedeh, Abbasalipourkabir Roghayeh, Nourian Alireza, Ziamajidi Nasrin
Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Mol Biol Rep. 2023 Mar;50(3):2357-2365. doi: 10.1007/s11033-022-08103-8. Epub 2022 Dec 29.
The rapidly increasing applications of zinc oxide nanoparticles (ZnO NPs) in various industries have led to growing concerns about their damaging influence on human health. The present research was designed to determine the protective action of vitamins (Vits) A, C and E on the heart toxicity induced by ZnO NPs.
Fifty-four male Wistar rats were allocated into 9 groups of 6 and then exposed to ZnO NPs (200 mg/kg), water (Control1), olive oil (Control2), Vit A (1000 IU/kg), Vit C (200 mg/kg), Vit E (100 IU/kg) and three groups were co-treated with ZnO and one of the Vits A, C or E. The oxidative stress situation was evaluated by measuring oxidative stress markers and the tissue antioxidant enzyme activity. Besides, the mRNA expression of Bcl-2 and Bax and caspase 3,7 activity were assessed. A histopathological examination was also performed to determine the rate of cardiac injury.
The results indicated that co-administration of ZnO NPs and the aforementioned Vits significantly reduced the total oxidant status and lipid peroxidation relative to the ZnO group (P < 0.05). Furthermore, the supplementation of vitamins, notably Vit E, decreased the ZnO NPs-induced oxidative damage by enhancing the activity of antioxidant enzymes compared to the ZnO NPs-fed rats (P < 0.05). Data also showed the mitigating effects of Vits against ZnO NPs-mediated apoptosis by suppressing the ratio of Bax/Bcl-2 expression and caspase 3,7 activity.
This study highlights the protective role of Vits A, C and E against ZnO NPs cardiotoxicity, though at different levels of effectiveness.
氧化锌纳米颗粒(ZnO NPs)在各行业的迅速广泛应用引发了人们对其对人类健康潜在危害的日益担忧。本研究旨在确定维生素A、C和E对ZnO NPs诱导的心脏毒性的保护作用。
将54只雄性Wistar大鼠分为9组,每组6只,分别暴露于ZnO NPs(200mg/kg)、水(对照1)、橄榄油(对照2)、维生素A(1000IU/kg)、维生素C(200mg/kg)、维生素E(100IU/kg),另有三组同时接受ZnO NPs与维生素A、C或E之一的联合处理。通过测量氧化应激标志物和组织抗氧化酶活性来评估氧化应激状况。此外,评估Bcl-2和Bax的mRNA表达以及半胱天冬酶3、7的活性。还进行了组织病理学检查以确定心脏损伤率。
结果表明,与ZnO组相比,ZnO NPs与上述维生素联合使用显著降低了总氧化剂状态和脂质过氧化(P<0.05)。此外,与喂食ZnO NPs的大鼠相比,补充维生素,尤其是维生素E,通过增强抗氧化酶的活性降低了ZnO NPs诱导的氧化损伤(P<0.05)。数据还显示,维生素通过抑制Bax/Bcl-2表达比值和半胱天冬酶3、7的活性,减轻了ZnO NPs介导的细胞凋亡。
本研究强调了维生素A、C和E对ZnO NPs心脏毒性的保护作用,尽管其有效性水平不同。